SCHEMBL1019166

SCHEMBL1019166

O=C=NC(Cl)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5440442 0.96
SCHEMBL28175944 0.77
SCHEMBL6893027 0.77
SCHEMBL11196496 0.72
SCHEMBL11196102 0.72
SCHEMBL11094162 0.72
SCHEMBL6505895 0.67
SCHEMBL11213385 0.67
SCHEMBL11042782 0.67 TSHR (0.30)
SCHEMBL11849288 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678869-B2 Atom or group transfer radical polymerization CARNEGIE MELLON UNIVERSITY (US) 2010-03-16 US claimed
EP-1642901-B1 Novel erythromycin derivatives PFIZER PROD INC (US) 2007-10-31 EP claimed
US-20060258826-A1 Atom or group transfer radical polymerization CARNEGIE MELLON UNIVERSITY 2006-11-16 US claimed
EP-1642901-A1 Novel erythromycin derivatives Pfizer Products Inc. (US) 2006-04-05 EP claimed
US-6825171-B2 MACROLIDE ANTIBIOTIC USEFUL IN THE TREATMENT OF A BROAD SPRECTRUM OF BACTERIAL INFECTIONS AND PROTOZOA INFECTIONS PFIZER, INC. 2004-11-30 US claimed
US-20040067897-A1 Novel erythromycin derivatives PFIZER INC. 2004-04-08 US claimed
EP-1044208-A1 ERYTHROMYCIN DERIVATIVES Pfizer Products Inc. (US) 2000-10-18 EP claimed
WO-1999035157-A1 NOVEL ERYTHROMYCIN DERIVATIVES PFIZER PRODUCTS INC. (US) 1999-07-15 WO claimed
WO-2025072355-A1 METHODS FOR AND COMPOSITIONS OF NON-PEG BIOCONJUGATES WITH ULTRA-HIGH DRUG-TO-AGENT RATIO BIOHYBRID SOLUTIONS HOLDINGS, INC. (US) 2025-04-03 WO disclosed
WO-2023061294-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 再鼎医药(上海)有限公司 2023-04-20 WO disclosed
US-11548888-B2 KRas G12C inhibitors Mirati Therapeutics, Inc. (US) 2023-01-10 US disclosed
US-11548888-B2 KRas G12C inhibitors Mirati Therapeutics, Inc. (US) 2023-01-10 US disclosed
EP-4087573-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2022-11-16 EP disclosed
CN-113620961-B Synthesis method of compound SCH-79797 深圳湾实验室 2022-05-27 CN disclosed
WO-1998040415-A1 IMPROVEMENTS IN ATOM OR GROUP TRANSFER RADICAL POLYMERIZATION CARNEGIE MELLON UNIVERSITY (US) 1998-09-17 WO disclosed
US-5747420-A HERBICIDES NIHON BAYER AGROCHEM K.K. (JP) 1998-05-05 US disclosed
EP-0711761-A1 Tetrazolinones NIHON BAYER AGROCHEM K.K. (JP) 1996-05-15 EP disclosed
US-4254260-A 3-Substituted-7-substituted alkanamido-3-cephem-4-carboxylic acid compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-03-03 US disclosed
US-4216215-A 7[(Furanyl-2-acetamido)-2-acetamido]cephalosporin derivatives PFIZER INC. (US) 1980-08-05 US disclosed
US-3944410-A Substituted oxadiazolidine dione herbicides VELSICOL CHEMICAL CORPORATION (US) 1976-03-16 US disclosed